Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety profile of darolutamide versus placebo: a systematic review and meta-analysis.
Turco F, Gillessen S, Treglia G, Fizazi K, Smith MR, Tombal B, Cathomas R, Buttigliero C, Di Maio M, Tucci M, Vogl UM. Turco F, et al. Among authors: gillessen s. Prostate Cancer Prostatic Dis. 2023 Dec 14. doi: 10.1038/s41391-023-00775-y. Online ahead of print. Prostate Cancer Prostatic Dis. 2023. PMID: 38097723 Review.
The Value of Tumour Markers in the Detection of Relapse-Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study.
Fischer S, Rothermundt C, Stalder O, Terbuch A, Hermanns T, Zihler D, Müller B, Fankhauser CD, Hirschi-Blickenstorfer A, Seifert B, Kluth LA, Ufe MP, Mingrone W, Templeton AJ, Fischer N, Rothschild S, Woelky R, Gillessen S, Cathomas R. Fischer S, et al. Among authors: gillessen s. Eur Urol Open Sci. 2023 Feb 20;50:57-60. doi: 10.1016/j.euros.2023.01.013. eCollection 2023 Apr. Eur Urol Open Sci. 2023. PMID: 36874175 Free PMC article.
Updated treatment recommendations for prostate cancer from the ESMO Clinical Practice Guideline considering treatment intensification and use of novel systemic agents.
Fizazi K, Gillessen S; ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Fizazi K, et al. Among authors: gillessen s. Ann Oncol. 2023 Jun;34(6):557-563. doi: 10.1016/j.annonc.2023.02.015. Epub 2023 Mar 21. Ann Oncol. 2023. PMID: 36958590 Free article. No abstract available.
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate Cancer.
Oprea-Lager DE, MacLennan S, Bjartell A, Briganti A, Burger IA, de Jong I, De Santis M, Eberlein U, Emmett L, Fizazi K, Gillessen S, Herrmann K, Heskamp S, Iagaru A, Jereczek-Fossa BA, Kunikowska J, Lam M, Nanni C, O'Sullivan JM, Panebianco V, Sala E, Sathekge M, Sosnowski R, Tilki D, Tombal B, Treglia G, Tunariu N, Walz J, Yakar D, Dierckx R, Sartor O, Fanti S. Oprea-Lager DE, et al. Among authors: gillessen s. Eur Urol. 2024 Jan;85(1):49-60. doi: 10.1016/j.eururo.2023.09.003. Epub 2023 Sep 22. Eur Urol. 2024. PMID: 37743194 Free article.
Antiandrogens as Therapies for COVID-19: A Systematic Review.
Cani M, Epistolio S, Dazio G, Modesti M, Salfi G, Pedrani M, Isella L, Gillessen S, Vogl UM, Tortola L, Treglia G, Buttigliero C, Frattini M, Pereira Mestre R. Cani M, et al. Among authors: gillessen s. Cancers (Basel). 2024 Jan 10;16(2):298. doi: 10.3390/cancers16020298. Cancers (Basel). 2024. PMID: 38254788 Free PMC article. Review.
Prognostic and Predictive Role of SPOP Mutations in Prostate Cancer: A Systematic Review and Meta-analysis.
Pedrani M, Salfi G, Merler S, Testi I, Cani M, Turco F, Trevisi E, Tortola L, Treglia G, Di Tanna GL, Vogl U, Gillessen S, Theurillat JP, Pereira Mestre R. Pedrani M, et al. Among authors: gillessen s. Eur Urol Oncol. 2024 May 3:S2588-9311(24)00103-2. doi: 10.1016/j.euo.2024.04.011. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38704358 Free article. Review.
303 results